These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3224162)

  • 21. Pharmacokinetics of propranolol after single and multiple dosing with sustained release propranolol or propranolol CR (innopran XL) , a new chronotherapeutic formulation.
    Sica D; Frishman WH; Manowitz N
    Heart Dis; 2003; 5(3):176-81. PubMed ID: 12783630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Racemic (R,S)-propranolol versus half-dosed optically pure (S)-propranolol in humans at steady state: Hemodynamic effects, plasma concentrations, and influence on thyroid hormone levels.
    Stoschitzky K; Lindner W; Egginger G; Brunner F; Obermayer-Pietsch B; Passath A; Klein W
    Clin Pharmacol Ther; 1992 Apr; 51(4):445-53. PubMed ID: 1563214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma concentrations and bioavailability of propranolol by oral, rectal, and intravenous administration in man.
    Cid E; Mella F; Lucchini L; Cárcamo M; Monasterio J
    Biopharm Drug Dispos; 1986; 7(6):559-66. PubMed ID: 3828485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of gugulipid on bioavailability of diltiazem and propranolol.
    Dalvi SS; Nayak VK; Pohujani SM; Desai NK; Kshirsagar NA; Gupta KC
    J Assoc Physicians India; 1994 Jun; 42(6):454-5. PubMed ID: 7852226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Propranolol pharmacokinetics in infants treated for Infantile Hemangiomas requiring systemic therapy: Modeling and dosing regimen recommendations.
    Del Frari L; Léauté-Labrèze C; Guibaud L; Barbarot S; Lacour JP; Chaumont C; Delarue A; Voisard JJ; Brunner V
    Pharmacol Res Perspect; 2018 Jun; 6(3):e00399. PubMed ID: 29736244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Racial differences in sensitivity to the negative chronotropic effects of propranolol in healthy men.
    Sowinski KM; Burlew BS; Johnson JA
    Clin Pharmacol Ther; 1995 Jun; 57(6):678-83. PubMed ID: 7781268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Racial differences in lymphocyte beta-receptor sensitivity to propranolol.
    Johnson JA
    Life Sci; 1993; 53(4):297-304. PubMed ID: 8392129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined high-performance liquid chromatographic procedure for measuring 4-hydroxypropranolol and propranolol in plasma: pharmacokinetic measurements following conventional and slow-release propranolol administration.
    Drummer OH; McNeil J; Pritchard E; Louis WJ
    J Pharm Sci; 1981 Sep; 70(9):1030-2. PubMed ID: 6101148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A pharmacokinetic interaction study of avitriptan and propranolol.
    Marathe PH; Greene DS; Kollia GD; Barbhaiya RH
    Clin Pharmacol Ther; 1998 Mar; 63(3):367-78. PubMed ID: 9542480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ethnic differences in secretion, sensitivity, and hepatic extraction of insulin in black and white Americans.
    Osei K; Schuster DP
    Diabet Med; 1994 Oct; 11(8):755-62. PubMed ID: 7851069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Propranolol disposition in patients with hepatosplenic schistosomiasis.
    Homeida MM; Ali HM; Arbab BM; Harron DW
    Br J Clin Pharmacol; 1987 Sep; 24(3):393-6. PubMed ID: 3663453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Randomized, Crossover Study on the Effect of Food on the Pharmacokinetic Characteristics of Morphine ARER (MorphaBond™ ER), an Abuse-Deterrent Formulation of Extended-Release Morphine.
    Kinzler ER; Pantaleon C; Iverson M; Aigner S
    Adv Ther; 2019 Sep; 36(9):2394-2401. PubMed ID: 31278694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of diltiazem and propranolol when administered alone and in combination.
    Dimmitt DC; Yu DK; Elvin AT; Giesing DH; Lanman RC
    Biopharm Drug Dispos; 1991 Oct; 12(7):515-23. PubMed ID: 1932613
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of D-propranolol following oral, intra-arterial and intraportal administration: contrasting effects of oral glucose pretreatment.
    Chow HH; Lalka D
    Biopharm Drug Dispos; 1993 Apr; 14(3):217-31. PubMed ID: 8490110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gender-dependent racial difference in disposition of cyclosporine among healthy African American and white volunteers.
    Min DI; Lee M; Ku YM; Flanigan M
    Clin Pharmacol Ther; 2000 Nov; 68(5):478-86. PubMed ID: 11103750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetic and pharmacodynamic evaluation during coadministration of nefazodone and propranolol in healthy men.
    Salazar DE; Marathe PH; Fulmor IE; Lee JS; Raymond RH; Uderman HD
    J Clin Pharmacol; 1995 Nov; 35(11):1109-18. PubMed ID: 8626885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative pharmacokinetics and pharmacodynamics of lisinopril and enalapril, alone and in combination with propranolol.
    Bendtsen F; Henriksen JH
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():139-45. PubMed ID: 2550636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of dosage release formulations on the pharmacokinetics of propranolol stereoisomers in humans.
    Bleske BE; Welage LS; Rose S; Amidon GL; Shea MJ
    J Clin Pharmacol; 1995 Apr; 35(4):374-8. PubMed ID: 7650226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of propranolol in healthy cats during euthyroid and hyperthyroid states.
    Jacobs G; Whittem T; Sams R; Calvert C; Ferguson D
    Am J Vet Res; 1997 Apr; 58(4):398-403. PubMed ID: 9099387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synergistic adverse hemodynamic interaction between oral verapamil and propranolol.
    Carruthers SG; Freeman DJ; Bailey DG
    Clin Pharmacol Ther; 1989 Oct; 46(4):469-77. PubMed ID: 2791449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.